1Fukui M. Guideline s for the diagnosis and treatment of sponta- neous occlusi on of the circle of Willi's(moyamoya disease ). Re- search Committee on Spontaneous Occlusion of the Circle of Willis(Moyamoya Disease )of the Ministry of Health and Wel- fare,Japan[J]. Clin Neurol Neurosurg,1997,99(suppl 2):238- 240.
2吴江.神经病学[M].2版.北京:人民卫生出版社,2010:8.
3Takeuchi K, Shimizu K. Hypogenesis of bilateral internal carot- id arteries[J]. No To Shinkei, 1957,9 : 37-43.
4Suzuki J, Takaku A. Cerebrovascular ' moyamoya' disease., dis ease showing abnormal net-llke vessels in base of brain [J]. Arch Neurol,1969,20:288- 299.
6[5]Sulpicio G,Soriano MD,Douglas B,et al.Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome[J].Neurosurgery,2002,50:544-549.
7[6]Yamamoto M,Aoyogi M,Fukai N,et al.Increase in prostaglandin E(2) production by interleukin-1 beta in arterial smooth muscle cells derived from patients with moyamoya disease[J].Circ Res,1999,85:913-918.
8[7]Yanagawa Y,Sugiura T,Suzuki K,et al.Moyamoya disease associated with positive findings for rheumatoid factor and myeloperoxidase-antineutrophil cytoplasmic antibody[J].West Indian Med J,2007,56:282-284.
9[8]Malek AM,Connors S,Robertson RL,et al.Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central system disorders[J].Pediatr Neurosureg,1997,24:182-189.
10[9]Hojo M,Hoshimaru M,Miyamoto S,et al.Role Of transforming growth factor 1 in the pathogenesis of moyamoya disease[J].J Neurosurg,1998,89:623-629.
